BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Cyclica launches Perturba Therapeutics, a spin out from the University of Toronto, creating the next-generation oncology biotech

  Cyclica Inc. (“Cyclica”), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline, today launches Perturba Therapeutics Inc. (“Perturba”), a spin out from the Stagljar Lab at the University of Toronto, Donnelly Centre for Cellular and Biomolecular Research.

  February 9, 2022

   · 

  5 min read
• Genetown

  CRISPR Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

  CRISPR Therapeutics announced that members of its senior management team are scheduled to participate in the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022, at 1:40 p.m. ET.

  February 9, 2022

   · 

  1 min read
• Business

  Pasithea Therapeutics Strengthens its Scientific Advisory Board with the Appointment of Preeminent Scientist Dr. Daniel Weinberger

  Pasithea Therapeutics Corp. today announced the appointment of Dr. Daniel Weinberger to its Scientific Advisory Board (“SAB”).

  February 9, 2022

   · 

  4 min read
• Biotech Beach

  Codex DNA to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

  Codex DNA, Inc., a pioneer in automated benchtop synthetic biology systems, announced that members of its management team will be participating in the SVB Leerink 11th Annual Global Healthcare Conference.

  February 9, 2022

   · 

  1 min read
• Biotech Bay

  RAPT Therapeutics to Participate in the 11th Annual SVB Leerink Healthcare Conference

  RAPT Therapeutics, Inc. announced that Brian Wong, M.D., Ph.D., President and CEO, will participate in a virtual fireside chat at the 11th Annual SVB Leerink Healthcare Conference on Wednesday, February 16, 2022 at 1:40 p.m. ET.

  February 9, 2022

   · 

  1 min read
• Biotech Beach

  Poseida Therapeutics to Host Virtual R&D Day on February 23, 2022

  Poseida Therapeutics, Inc. today announced that it will host a virtual R&D Day at 10:00 am - 1:30 pm ET / 7:00 - 10:30 am PT on Wednesday February 23, 2022.

  February 9, 2022

   · 

  4 min read
• Business

  Unchained Labs adds biopharma vet Laura Hamill to the Board

  Unchained Labs announced the addition of Laura Hamill to its Board today.

  February 9, 2022

   · 

  1 min read
• Business

  Blueprint Medicines to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 16, 2022

  Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Wednesday, February 16, 2022 to report its fourth quarter and full year 2021 financial results and provide a corporate update.

  February 9, 2022

   · 

  1 min read
• Business

  Arc Bio Joins Microbiome Therapeutics Innovation Group

  The Microbiome Therapeutics Innovation Group (MTIG) today announced the addition of Arc Bio to its coalition of companies leading the research and development of FDA-approved microbiome therapeutic drugs and microbiome-based products.

  February 9, 2022

   · 

  3 min read
• Business

  AavantiBio Announces Formation of Scientific Advisory Board

  AavantiBio today announced the formation of its Scientific Advisory Board (SAB) and its members.

  February 9, 2022

   · 

  6 min read